| Financial Year |
March 31 2023 |
| Monetary Funds |
465,089,188.36 |
| Held-for-trading Financial Assets |
300,000,000.00 |
| Notes Receivable |
14,286,833.00 |
| Accounts Receivable |
971,448,047.97 |
| Advances to Suppliers |
28,778,924.56 |
| Other Receivables |
17,494,178.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
747,704,217.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,927,402.57 |
| Total Current Assets |
2,660,136,308.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
148,649,188.19 |
| Long-term Equity Investment |
9,112,722.92 |
| Investment Properties |
3,527,939.01 |
| Fixed Assetes |
189,235,138.18 |
| Under-construction Projects |
72,974,802.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,262,564.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,866,414.08 |
| Deferred Income Tax Assets |
22,685,654.55 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
564,020,105.57 |
| Total Assets |
3,224,156,414.09 |
| Short-Term Loans |
491,400,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
438,947,863.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
144,936,569.06 |
| Taxes Payable |
4,916,326.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,211,502.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,514,974.84 |
| Other Current Liabilities |
16,320,431.60 |
| Sub-Total of Current Liabilities |
1,264,596,944.81 |
| Long-term Loans |
116,050,000.00 |
| Bonds Payable |
522,741,189.51 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,550,959.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
686,830,739.27 |
| Total Liabilities |
1,951,427,684.08 |
| Paid-In Capital(Or Share Stock) |
494,203,916.00 |
| Capital Surplus |
155,442,705.28 |
| Surplus Reserve |
25,289,894.01 |
| LESS:Treasury Stock |
24,994,000.29 |
| Undistributed Profits |
564,596,560.15 |
| Minority Stockholder's Interest |
3,511,323.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,269,217,406.58 |
| Owner's Equity（Stockholder's Equity） |
1,272,728,730.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,224,156,414.09 |
